Amjevita 55513-0482-02
Generic: Adalimumab-Atto
- Manufacturer
- Amgen, Inc
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 14, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761024
Need to source Amjevita? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab | 40 mg/.4mL |
Drug Class
Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]
Selected Package
55513-0482-02Selected2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE
Other packages for this product(1)
1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE